Morocco’s First Cannabis-Based Medicines: A New Era of Treatment
Introduction
Morocco is stepping confidently into a new chapter of medical innovation. With the first cannabis-derived medicines now in development, the country is transforming a once-illegal plant into a beacon of therapeutic hope. Under the framework of Law 13-21, Morocco is positioning itself as a pioneer in medical cannabis across Africa and the MENA region.
1. A Historic Milestone in Moroccan Healthcare
In early 2025, Moroccan biotech company Pharma 5 announced its preparations to release the nation’s first domestically produced cannabis-based medicine. This pharmaceutical breakthrough is a direct result of the government’s commitment to regulating and legalizing the use of cannabis for therapeutic purposes.
The drug, intended for treating epilepsy and certain types of chronic pain, will be fully compliant with Moroccan health regulations and produced under GACP and GMP conditions.
2. Backed by Law 13-21
This advancement wouldn’t be possible without Law 13-21, Morocco’s landmark cannabis legislation. Enacted in 2021, the law legalizes the cultivation, processing, and commercialization of cannabis for medical, pharmaceutical, and industrial uses. The law ensures every step—from farming to laboratory—is tightly regulated, safe, and traceable.
3. Pharma 5 and National Cannabis Agency Collaboration
Pharma 5’s move to develop cannabis-based medicine is closely aligned with the strategy set by the National Agency for the Regulation of Cannabis Activities (ANRAC). By choosing to produce locally, Morocco reduces its reliance on imported treatments, cuts patient costs, and opens up new pharmaceutical export potential.
4. A Win for Patients and Farmers
This step is more than a medical breakthrough—it’s a win for thousands of small farmers now growing legally under government-issued licenses. Cannabis, once associated with criminalization, is now a source of health, economic inclusion, and regional development.
Patients with epilepsy, MS, chronic pain, and other qualifying conditions will soon have access to Moroccan-made cannabis-based treatments—affordable, accessible, and safe.
5. What’s Next?
As Morocco ramps up its medical cannabis program, new research, development, and international partnerships are expected. Cannabis-derived medicines for pediatric conditions, cancer-related symptoms, and more are on the horizon.
With the government’s continued support and strict compliance systems, Morocco’s medical cannabis future looks bright.
Conclusion
The introduction of Morocco’s first cannabis-derived medicines is a bold and visionary step. It merges science, law, and local empowerment, setting a new regional standard. Morocco is not just growing cannabis—it’s cultivating healing, hope, and a sustainable future.
